Foster Dykema Cabot & Partners’s CRISPR Therapeutics CRSP Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$648	Hold
2025 Q2	$486	Hold
2025 Q1	$340	Hold
2024 Q4	$394	Hold
2024 Q3	$470	Hold
2024 Q2	$540	Hold
2024 Q1	$682	Hold
2023 Q4	$626	Buy